Intraoperative technological advances and new frontiers in precision glioma surgery
-
By
-
Christina Abi Faraj
-
Christopher C. Young
-
Thomas H. Beckham
-
Jeffrey S. Weinberg
-
July 4, 2026
-
Clinical Scorecard: Innovations in Technology and Emerging Approaches in Precision Surgery for Gliomas
At a Glance
| Category | Detail |
|---|
| Condition | Diffuse Gliomas |
| Key Mechanisms | Maximal safe surgical resection, intraoperative technologies, and local drug delivery strategies. |
| Target Population | Adults with newly diagnosed or recurrent high-grade gliomas. |
| Care Setting | Neurosurgical operating rooms. |
Key Highlights
- Maximal safe resection is associated with improved progression-free and overall survival.
- Achieving > 20% supramarginal resection significantly improves overall survival.
- Intraoperative technologies include neuronavigation, functional mapping, and fluorescence-guided surgery.
- Local drug delivery strategies, such as Gliadel® wafers, bypass the blood-brain barrier.
- Functional mapping techniques like fMRI enhance tumor delineation and protect eloquent brain areas.
Guideline-Based Recommendations
Diagnosis
- Use functional MRI for preoperative mapping of eloquent cortex.
Management
- Maximal safe surgical resection followed by concurrent radiotherapy and temozolomide.
Monitoring & Follow-up
- Monitor for postoperative neurological deficits that may affect survival.
Risks
- Aggressive resection in eloquent areas may lead to neurological deficits.
Patient & Prescribing Data
Patients with newly diagnosed or recurrent high-grade gliomas.
Local drug delivery methods can enhance treatment efficacy by bypassing the blood-brain barrier.
Clinical Best Practices
- Combine fMRI data with neuronavigation for optimal resection.
- Consider supramarginal resection to improve survival outcomes.
Related Resources & Content
